Prosecution Insights
Last updated: July 17, 2026

Brown Rudnick, LLP

86 pending office actions • 46 clients • 80 examiners • 53 art units • 0 of 86 (0%) have an AI response strategy ready • 99 patents granted in the last 365 days

Quality Metrics (n=52232 apps, methodology: how we score firms)

88.4%
Allowance Rate
n=52232
+0.73σ
Allowance Rate (norm)
n=52232
4.2
OAs to Allowance
n=32510
+0.16σ
OAs to Allow (norm)
n=32510
1254 days
Time to Allowance
n=32510
+6.3pp
Interview Lift
n=52232
34.7%
RCE Rate
n=52232
3.5%
Appeal Rate
n=52232

Rejection Performance (% of received rejections ultimately overcome)

85.4%
§101 Overcome
n=794
87.8%
§102 Overcome
n=5778
84.0%
§103 Overcome
n=21986
91.6%
§112 Overcome
n=3510

Specialization & Scale

A61B, A61N, A61M
Top CPC Subclasses
51%
Top-3 CPC Share
n=52232
15
Practitioners
n=52232
3482.1
Apps / Practitioner
n=52232

Portfolio Summary

86
Total Pending OAs
59
Non-Final OAs
27
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 46 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

21
Overdue
3
Due this week
14
Due this month
5
Due in next 60 days
3
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 46 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (21)Due ≤ 7 days (3)Due ≤ 30 days (14)Due ≤ 60 days (5)Due later (3)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (5%)
58
Medium (67%)
18
Easy (21%)
6
Unknown (7%)

Rejection Statute Mix

BucketCases
§101 only4 (5%)
§103 only47 (55%)
§102 only11 (13%)
§112 only13 (15%)
Double-patenting only5 (6%)
No statute on record6 (7%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

42
Life Sciences
49% of docket
3
Information Tech
3% of docket
2
Communications
2% of docket
4
Semiconductors
5% of docket
27
Mechanical / Eng
31% of docket
8
Business / Other
9% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

860 h
Manual time on pending OAs
172 h
Time saved (low, 20%)
301 h
Time saved (mid, 35%)
7.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
CELESTINE, NYROBI I 3 81.7% +22.6%
TIWARI, VYOMA SHUBHAM 3 30.2% +46.7%
VOLKOV, ALEXANDER ALEXANDROVIC 2 29.1% +23.8%
BEGEMAN, ANDREW W 2 42.9% +20.1%
SMITH, JACOB A 1 81.6% +18.0%
PARSLEY, DAVID J 1 54.0% +28.3%
SELLS, JAMES D 1 81.2% +12.0%
POTRATZ, DANIEL B 1 73.6% +35.3%
TEHRANI, DANIEL 1 60.0% +49.3%
TOLEDO-DURAN, EDWIN J 1 69.7% +32.5%

Quick Wins (5)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18763063 SYSTEMS AND METHODS FOR TISSUE ANALYSIS AND VISUALIZATION CELESTINE, NYROBI I 3d overdue
19261214 HYBRID INSERTER/WRAPPER SYSTEM SMITH, JACOB A 22d
18763091 SYSTEMS AND METHODS FOR EVENT-DRIVEN ULTRASOUND SAMPLING CELESTINE, NYROBI I 41d
19075578 SYSTEMS AND METHODS FOR PRINTING AND APPLYING LABELS SELLS, JAMES D
18763044 SYSTEMS AND METHODS FOR ROTATIONAL ULTRASOUND FOCUSING CELESTINE, NYROBI I

Hard Cases (6)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18615309 SYSTEM FOR PROVIDING SYNCHRONIZED SHARING OF AUGMENTED REALITY CONTENT IN REAL TIME ACROSS MULTIPLE DEVICES FIORILLO, JAMES N 66d overdue
16724092 METAL-ANTIBODY TAGGING AND PLASMA-BASED DETECTION VOLKOV, ALEXANDER ALEXANDROVIC 46d overdue
18143321 SYSTEM AND METHOD FOR IDENTIFYING A DEVIATION OF AN OPERATOR OF A VEHICLE FROM A DOCTRINE BULLINGTON, ROBERT P 30d overdue
18884815 IN VITRO ASSAY TO PREDICT CARDIOTOXICITY VOLKOV, ALEXANDER ALEXANDROVIC
18830947 SYSTEMS AND METHODS FOR TREATING PULMONARY EDEMA WIEST, PHILIP R
18798181 SYSTEMS AND METHODS FOR TRIAGING HIGH RISK MESSAGES STARKS, WILBERT L

Interview Candidates (16)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
19186177 SHELLFISH SHUCKING KNIFE PARSLEY, DAVID J 78d overdue
18404231 SYSTEM FOR OPTIMIZING AN IMAGING APERTURE BEGEMAN, ANDREW W 46d overdue
16724092 METAL-ANTIBODY TAGGING AND PLASMA-BASED DETECTION VOLKOV, ALEXANDER ALEXANDROVIC 46d overdue
18404174 IMAGING ARRAY WITH BIAS APERTURE SELECTION BEGEMAN, ANDREW W 42d overdue
18763063 SYSTEMS AND METHODS FOR TISSUE ANALYSIS AND VISUALIZATION CELESTINE, NYROBI I 3d overdue
19261214 HYBRID INSERTER/WRAPPER SYSTEM SMITH, JACOB A 22d
17480501 CONTROLLING PROXIMITY OF IMMUNE CELL RECEPTORS TIWARI, VYOMA SHUBHAM 22d
18763091 SYSTEMS AND METHODS FOR EVENT-DRIVEN ULTRASOUND SAMPLING CELESTINE, NYROBI I 41d

Client Portfolio (46 clients)

Top Art Units

Art UnitApps
37986
16344
37943
16153
37913
16772
16292
37962
16912
16322

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19261214 HYBRID INSERTER/WRAPPER SYSTEM DMT SOLUTIONS GLOBAL CORPORATION SMITH, JACOB A 3731 §112 Non-Final OA 22d Pending Jul 07, 2025
19186177 SHELLFISH SHUCKING KNIFE Coastal Creative LLC PARSLEY, DAVID J 3643 §103 Non-Final OA 78d overdue Pending Apr 22, 2025
19075578 SYSTEMS AND METHODS FOR PRINTING AND APPLYING LABELS DMT SOLUTIONS GLOBAL CORPORATION SELLS, JAMES D §103 Non-Final OA Pending Mar 10, 2025
19042314 DEVICES, SYSTEMS, AND METHODS FOR PROVIDING SECURE BRANCH-FREE PASSWORD AUTHENTICATION Tropic Square S.R.O POTRATZ, DANIEL B 2491 §112 Non-Final OA Pending Jan 31, 2025
18877731 NEUROMODULATION OF TWO OR MORE NEURONAL TARGETS IN TREATMENT OF A MEDICAL CONDITION Reshape Lifesciences, Inc. TEHRANI, DANIEL §102 Non-Final OA Pending Dec 20, 2024
18976947 RAPID LEACHING AND DEWATERING TECHNOLOGY (RLDT) FOR EX-SITU REMEDIATION OF PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) AND OTHER CONTAMINANTS IN SOIL Next Earth Environmental LLC, C/O Hrp Associates, Inc. TOLEDO-DURAN, EDWIN J 3678 §103 Non-Final OA Pending Dec 11, 2024
18964231 AUTOMATED SKIN CLOSURE SYSTEM Opus Ksd Inc. IGBOKO, CHIMA U §103 Non-Final OA Pending Nov 29, 2024
18958497 MAILING OPTIMIZATION SYSTEMS AND METHODS DMT SOLUTIONS GLOBAL CORPORATION DULANEY, BENJAMIN O §103 Non-Final OA Pending Nov 25, 2024
18888762 SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT USING HANDHELD DEVICE Neurent Medical Limited BOCK, ABIGAIL MARIE 3794 DP Non-Final OA Pending Sep 18, 2024
18884815 IN VITRO ASSAY TO PREDICT CARDIOTOXICITY Stemina Biomarker Discovery, Inc. VOLKOV, ALEXANDER ALEXANDROVIC 1677 §102 Non-Final OA Pending Sep 13, 2024
18830947 SYSTEMS AND METHODS FOR TREATING PULMONARY EDEMA White Swell Medical Ltd. WIEST, PHILIP R §101 Final Rejection Pending Sep 11, 2024
18798181 SYSTEMS AND METHODS FOR TRIAGING HIGH RISK MESSAGES Crisis Text Line, Inc. STARKS, WILBERT L 2122 §101 Final Rejection Pending Aug 08, 2024
18833637 POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS Purdue Research Foundation BURKE, MATTHEW RYAN 1619 §103 Non-Final OA Pending Jul 26, 2024
18780727 METHODS OF TREATING HEART FAILURE WITH HIBERNATING MYOCARDIUM USING MODIFIED FORMS OF TRIMETAZIDINE Imbria Pharmaceuticals, Inc. TRAN, ERIC 1629 Non-Final OA Pending Jul 23, 2024
18702356 VAGUS NERVE NEUROMODULATION FOR THE TREATMENT OF THE HYPOGLYCEMIC STATE Reshape Lifesciences, Inc. PATEL, NIKETA I 3796 §102 Non-Final OA 19d Pending Jul 18, 2024
18763063 SYSTEMS AND METHODS FOR TISSUE ANALYSIS AND VISUALIZATION Luma Vision Limited CELESTINE, NYROBI I 3798 §103 Final Rejection 3d overdue Pending Jul 03, 2024
18763091 SYSTEMS AND METHODS FOR EVENT-DRIVEN ULTRASOUND SAMPLING Luma Vision Limited CELESTINE, NYROBI I 3798 §103 Final Rejection 41d Pending Jul 03, 2024
18763044 SYSTEMS AND METHODS FOR ROTATIONAL ULTRASOUND FOCUSING Luma Vision Limited CELESTINE, NYROBI I 3798 §103 Non-Final OA Pending Jul 03, 2024
18746622 DETECTING AN ANALYTE IN A MEDIUM Orb Xyz, Inc. GUNBERG, EDWIN C 2884 §103 Non-Final OA 35d Pending Jun 18, 2024
18680094 FRAUD DETECTION AND PREVENTION SYSTEM Brightwell Payments, Inc. HILMANTEL, ADAM J 3691 §103 Non-Final OA 26d Pending May 31, 2024
18667133 BIN OUTPUT EXPANDER DEVICES, SYSTEMS, AND METHODS DMT SOLUTIONS GLOBAL CORPORATION DEVINE, MOLLY K 3653 §103 Final Rejection 86d overdue Pending May 17, 2024
18699539 SYSTEMS AND METHODS FOR TREATING FLUID OVERLOAD Aquapass Ltd. SKUBINNA, CHRISTINE J DP Non-Final OA Pending Apr 08, 2024
18624508 METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION FRACTION USING MODIFIED FORMS OF TRIMETAZIDINE Imbria Pharmaceuticals, Inc. SHIAO, REI TSANG 1691 DP Non-Final OA Pending Apr 02, 2024
18615309 SYSTEM FOR PROVIDING SYNCHRONIZED SHARING OF AUGMENTED REALITY CONTENT IN REAL TIME ACROSS MULTIPLE DEVICES Iris Xr Inc. FIORILLO, JAMES N 2444 §101 Final Rejection 66d overdue Pending Mar 25, 2024
18692014 VIRUS COMPOSITIONS TO EFFICIENTLY TARGET THE NERVOUS SYSTEM AND THE LUNGS Capsida Biotherapeutics, Inc. BOESEN, AGNIESZKA 1632 §112 Non-Final OA Pending Mar 14, 2024
18581879 ON-PREMISES SMARTBOX Pt Intermediate Holdings Iv, LLC BROWN, VERNAL U 2686 §103 Final Rejection 17d overdue Pending Feb 20, 2024
18436332 DEVICES AND METHODS FOR TREATING EDEMA White Swell Medical Ltd. DOUBRAVA, JOHN A §102 Non-Final OA Pending Feb 08, 2024
18143154 Oral rinse, nasal spray and methods for prevention of COVID-19 by lowering viral load of COVID-19 Rucker Capital Advisors WORSHAM, JESSICA N 1615 §103 Non-Final OA Pending Feb 08, 2024
18427093 PROSTATE MEASUREMENT SYSTEM Medicametrix, Inc. SHAH, JAY B 3791 §103 Non-Final OA 45d overdue Pending Jan 30, 2024
18421550 COMBINATION THERAPY FOR TREATMENT OF CANCER Pmv Pharmaceuticals, Inc. PUTTLITZ, KARL J §103 Non-Final OA Pending Jan 24, 2024
18411217 DEVICES FOR USE IN ROBOT-ASSISTED MEDICAL PROCEDURES Edge Surgical, Inc. SEVILLA, CHRISTIAN ANTHONY 3775 §102 Non-Final OA Pending Jan 12, 2024
18406541 SURGICAL DEPTH INSTRUMENT Edge Surgical, Inc. MERENE, JAN CHRISTOP L 3773 §112 Final Rejection 3d overdue Pending Jan 08, 2024
18404174 IMAGING ARRAY WITH BIAS APERTURE SELECTION Oneprojects Design And Innovation Ltd. BEGEMAN, ANDREW W 3798 §103 Final Rejection 42d overdue Pending Jan 04, 2024
18404231 SYSTEM FOR OPTIMIZING AN IMAGING APERTURE Oneprojects Design And Innovation Ltd. BEGEMAN, ANDREW W 3798 §103 Final Rejection 46d overdue Pending Jan 04, 2024
18575558 METHODS AND DEVICES FOR MODULATING ELECTROLYTE EXCRETION Aquapass Ltd. NGUYEN, NGOC-ANH THI 1615 §102 Non-Final OA Pending Dec 29, 2023
18532735 COMPOSITIONS FOR PRE-SURGICAL NUTRITIONAL SUPPLEMENTS Tm Nutrition LLC TRAN, SUSAN T 1615 §103 Non-Final OA 14d Pending Dec 07, 2023
18519342 MASS SPECTROMETRY ANALYSIS OF MICROORGANISMS IN SAMPLES Purdue Research Foundation KIPOUROS, HOLLY MICHAELA 1799 §103 Final Rejection Pending Nov 27, 2023
18563569 ION FOCUSING AND MANIPULATION Purdue Research Foundation CHANG, HANWAY 2878 §103 Non-Final OA 19d overdue Pending Nov 22, 2023
18512306 LRRK2 INHIBITORS AND USES THEREOF Neuron23, Inc. CHAO, ALLEN 1622 §102 Non-Final OA Pending Nov 17, 2023
18290257 PRODUCTION OF ENGINEERED T CELLS FROM STEM CELLS Appia Bio, Inc. SMITH, ADAM MICHAEL 1638 §103 Non-Final OA 55d Pending Nov 10, 2023
18388634 UNMANNED FULLY AUTONOMOUS VENDING KIOSK Pt Intermediate Holdings Iv, LLC GLASS, RUSSELL S 3627 §103 Final Rejection Pending Nov 10, 2023
18387648 SYSTEMS AND METHODS FOR MAILSTREAM POSTAGE PRESERVATION DMT SOLUTIONS GLOBAL CORPORATION DETWEILER, JAMES M 3621 §103 Non-Final OA 46d overdue Pending Nov 07, 2023
18289186 MODEL OPTIMIZED DRUG AND DRUG COMBINATIONS FOR TREATING CANCERS My Personal Therapeutics BURKHART, MICHAEL D 1638 §102 Non-Final OA Pending Nov 01, 2023
18288910 RECOMBINANT AAVS FOR DELIVERY TO CENTRAL NERVOUS SYSTEM AND BRAIN VASCULATURE California Institute Of Technology BOWLES, DAVID PAUL 1632 DP Non-Final OA Pending Oct 30, 2023
18287357 MULTIPLEXED ELECTROSPRAY IONIZATION SOURCES USING ORTHOGONAL INJECTION INTO AN ELECTRODYNAMIC ION FUNNEL Purdue Research Foundation EINHORN, MICA JILLIAN 2881 §103 Non-Final OA 75d Pending Oct 18, 2023
18554382 WNT AGONISTS FOR PREVENTION OF CANCER Academish Medisch Centrum DAVIS, BRIAN J 1614 §103 Non-Final OA 70d Pending Oct 06, 2023
18284407 SELECTED AAV COMPOSITIONS HAVING PREFERRED BRAIN ENRICHMENT Capsida, Inc. BANERJEE, KOYELI 1658 §112 Non-Final OA 14d Pending Sep 27, 2023
18367728 METHODS OF PRODUCING MIXED CHIMERISM AFTER A SOLID ORGAN TRANSPLANT Medeor Therapeutics, Inc. LEE, YIE CHIA 1642 Other Non-Final OA 6d Pending Sep 13, 2023
18367630 BLOOD COLLECTION DEVICES AND METHODS Health Made Easy LOPEZ, SEVERO ANTON P 3791 §103 Final Rejection Pending Sep 13, 2023
18280891 METHYL-SUBSTITUTED PYRIDINE AND PYRIDAZINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS OF THEIR USE Lieber Institute, Inc. LADD, CAROLYN LOUISE 1622 §102 Non-Final OA Pending Sep 07, 2023
18223157 NOVEL WALL SHEAR STRESS (WSS) ESTIMATION METHOD FOR 4D FLOW MRI Purdue Research Foundation MALDONADO, STEVEN 3797 §103 Final Rejection Pending Jul 18, 2023
18198538 SYSTEMS AND METHODS FOR TISSUE EVALUATION AND CLASSIFICATION Oneprojects Design And Innovation Ltd. DRYDEN, EMMA ELIZABETH 2677 §103 Final Rejection 9d Pending May 17, 2023
18036549 KINASE MODULATORS AND METHODS OF USE THEREOF Neuron23, Inc. MCDOWELL, BRIAN E 1624 §112 Non-Final OA 29d Pending May 11, 2023
18143321 SYSTEM AND METHOD FOR IDENTIFYING A DEVIATION OF AN OPERATOR OF A VEHICLE FROM A DOCTRINE Elbit Systems Ltd. BULLINGTON, ROBERT P 3715 §101 Non-Final OA 30d overdue Pending May 04, 2023
18133619 AUTOMATED BEHAVIOR MONITORING AND MODIFICATION SYSTEM Mindfulgarden Digital Health, Inc. TRAN, LARA LINH 3791 §103 Non-Final OA 8d overdue Pending Apr 12, 2023
18030346 SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT Neurent Medical Limited GIULIANI, THOMAS ANTHONY 3794 §102 Non-Final OA 14d Pending Apr 05, 2023
18030349 SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT Neurent Medical Limited FOWLER, DANIEL WAYNE 3794 §103 Non-Final OA Pending Apr 05, 2023
18177566 COMPOSITIONS AND METHODS FOR CROSSING BLOOD BRAIN BARRIER California Institute Of Technology BORGEEST, CHRISTINA M 1675 §112 Non-Final OA 63d Pending Mar 02, 2023
18022056 ADENO-ASSOCIATED VIRUS COMPOSITIONS HAVING PREFERRED EXPRESSION LEVELS California Institute Of Technology SIFFORD, JEFFREY MARK 1671 §103 Non-Final OA 13d Pending Feb 17, 2023
18104364 Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase Kadmon Corporation, LLC ANDERSON, REBECCA L 1626 §103 Final Rejection 132d overdue Pending Feb 01, 2023
17885946 CIRCADIAN SLEEP STAGING Cerno Health Inc. WELCH, HALLE MARGARET 3796 §103 Non-Final OA 7d Pending Aug 11, 2022
17720036 FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS Debut Biotechnology, Inc. BREEN, KIMBERLY CATHERINE 1657 §103 Non-Final OA Pending Apr 13, 2022
17720020 FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS Debut Biotechnology, Inc. PAK, YONG D 1652 §103 Non-Final OA Pending Apr 13, 2022
17720031 FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS Debut Biotechnology, Inc. EPSTEIN, TODD MATTHEW 1652 §103 Final Rejection 60d Pending Apr 13, 2022
17720006 FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS Debut Biotechnology, Inc. STEADMAN, DAVID J 1656 Other Non-Final OA 29d Pending Apr 13, 2022
17695073 STRUCTURED SUBSTRATES FOR OPTICAL SURFACE PROFILING Trustees Of Boston University FLINDERS, JEREMY C 1684 §102 Non-Final OA 7d Pending Mar 15, 2022
17679568 METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION Pmv Pharmaceuticals, Inc. JOHNSON, CHRISTOPHER LINDSAY 1691 Other Non-Final OA Pending Feb 24, 2022
17609114 INTEGRATED MICROFLUIDIC PROBE (IMFP) AND METHODS OF USE THEREOF Purdue Research Foundation LOGIE, MICHAEL J 2881 §103 Final Rejection 51d overdue Pending Nov 05, 2021
17509535 SYSTEMS AND METHODS FOR REDUCING PRESSURE AT AN OUTFLOW OF A DUCT White Swell Medical Ltd. NGO, MEAGAN N 3781 §103 Final Rejection Pending Oct 25, 2021
17495144 SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT Neurent Medical Limited SHAFQAT, AMY JEANETTE 3798 §103 Non-Final OA 12d Pending Oct 06, 2021
17480454 ENGINEERED IMMUNE CELLS THAT MODULATE RECEPTOR EXPRESSION A2 Biotherapeutics, Inc. JOHANSEN, PETER N. 1644 §112 Non-Final OA Pending Sep 21, 2021
17480476 ENGINEERED IMMUNE CELLS WITH MULTIPLEX AND LOCALIZED ACTIVITY A2 Biotherapeutics, Inc. TIWARI, VYOMA SHUBHAM 1634 §112 Non-Final OA Pending Sep 21, 2021
17480501 CONTROLLING PROXIMITY OF IMMUNE CELL RECEPTORS A2 Biotherapeutics, Inc. TIWARI, VYOMA SHUBHAM 1634 §112 Non-Final OA 22d Pending Sep 21, 2021
17480462 ENGINEERING IMMUNE CELLS BASED ON ANTIGEN LEVELS A2 Biotherapeutics, Inc. TIWARI, VYOMA SHUBHAM 1634 §112 Non-Final OA Pending Sep 21, 2021
17439763 METHODS OF TREATING CANCER USING TRIMETAZIDINE-BASED COMPOUNDS Imbria Pharmaceuticals, Inc. SCHMIDT, IZABELA MARIA 1621 Other Non-Final OA 11d overdue Pending Sep 15, 2021
17359714 MODIFIED RELEASE FORMULATIONS OF MODIFIED FORMS OF TRIMETAZIDINE Imbria Pharmaceuticals, Inc. GONZALEZ, LUISALBERTO 1624 DP Non-Final OA 128d overdue Pending Jun 28, 2021
17359726 MODIFIED RELEASE FORMULATIONS OF MODIFIED FORMS OF TRIMETAZIDINE Imbria Pharmaceuticals, Inc. HUI, SAN MING R 1627 §103 Final Rejection 17d overdue Pending Jun 28, 2021
17348488 METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION Pmv Pharmaceuticals, Inc. ENGLISH, CONNOR KENNEDY 1625 §112 Final Rejection Pending Jun 15, 2021
17341834 NON-THROMBOGENIC DEVICES FOR TREATING EDEMA White Swell Medical Ltd. TRAN, THIEN JASON 3792 §103 Final Rejection Pending Jun 08, 2021
17323683 CBX8 CHROMDOMAIN INHIBITORS AND THE USES THEREOF Purdue Research Foundation NIEBAUER, RONALD T 1658 §103 Non-Final OA Pending May 18, 2021
17274950 ALKYNYL NICOTINAMIDE COMPOUNDS AS KINASE INHIBITORS Purdue Research Foundation MCMILLIAN, KARA RENITA 1623 §103 Final Rejection 14d Pending Mar 10, 2021
17081417 COMPOSITIONS AND METHODS FOR TARGETED NUCLEIC ACID SEQUENCE ENRICHMENT AND HIGH EFFICIENCY LIBRARY GENERATION Nugen Technologies, Inc. BERTAGNA, ANGELA MARIE 1681 §103 Final Rejection 14d Pending Oct 27, 2020
16881375 DOSING METHODS FOR TREATING INFLAMMATORY BOWEL CONDITIONS Intact Therapeutics, Inc. NEAGU, IRINA 1629 Other Final Rejection 46d overdue Pending May 22, 2020
16757655 METHOD OF TAGGING NUCLEIC ACID SEQUENCES, COMPOSITION AND USE THEREOF Argentag Corporation WOITACH, JOSEPH T 1687 §103 Non-Final OA 45d overdue Pending Apr 20, 2020
16775461 Device and method for multidimensional cell culture Premas Biotech Pvt Ltd. KASAYAN, KATRIEL BARCELLANO 1634 §112 Final Rejection 40d Pending Jan 29, 2020
16724092 METAL-ANTIBODY TAGGING AND PLASMA-BASED DETECTION Purdue Research Foundation VOLKOV, ALEXANDER ALEXANDROVIC 1677 §103 Final Rejection 46d overdue Pending Dec 20, 2019

Managing Brown Rudnick, LLP's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month